Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 15:08:20 ET
Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2025 Earnings Call Transcript
Rhythm Pharmaceuticals Inc.
NASDAQ: RYTM
RYTM Trading
1.53% G/L:
$89.63 Last:
1,828,196 Volume:
$96.71 Open:
RYTM Latest News
March 20, 2026 12:58:00 pm
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
March 19, 2026 06:30:00 pm
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
March 16, 2026 04:01:00 pm
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
RYTM Stock Data
$6,891,165,143
62,665,157
0.73%
95
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
